Literature DB >> 1589908

Therapeutic potential of cytokine manipulation.

B Henderson1, S Blake.   

Abstract

Interleukin 1 is just one of a large, growing, collection of potent cytokines that are produced by a variety of cells and have a myriad of overlapping activities. Many of these cytokines have important pathophysiological actions in diseases ranging from rheumatoid arthritis to AIDS. Selective inhibition of the synthesis or of the action of specific cytokines may have therapeutic benefit. In this review, Brian Henderson and Simon Blake discuss the ways in which cytokine function could be manipulated pharmacologically for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589908     DOI: 10.1016/0165-6147(92)90052-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  9 in total

1.  In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.

Authors:  J M Reimund; S Dumont; C D Muller; J S Kenney; M Kedinger; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 2.  Macrophages in CNS remyelination: friend or foe?

Authors:  L T Diemel; C A Copelman; M L Cuzner
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 3.  Therapeutic modulation of cytokines.

Authors:  B Henderson
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

4.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.

Authors:  P Akarasereenont; Y S Bakhle; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Inhibitory effects of pentoxifylline on LPS-induced leukocyte adhesion and macromolecular extravasation in the microcirculation.

Authors:  D Seiffge; T Bissinger; E Kremer; V Laux; R Schleyerbach
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

7.  An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver.

Authors:  R Mancini; A Benedetti; A M Jezequel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies.

Authors:  D E Hu; Y Hori; M Presta; G A Gresham; T P Fan
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

Review 9.  Inflammation, acid and ulcers.

Authors:  M J Muller; R H Hunt
Journal:  Yale J Biol Med       Date:  1994 May-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.